Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3761678011 | Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3761679015 | Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3761680017 | Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Aliskiren and amlodipine and hydrochlorothiazide only product in oral dose form | true | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator value | 5 | false | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has BoSS | Aliskiren | true | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has BoSS | Amlodipine | true | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has precise active ingredient | Amlodipine besylate | true | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has precise active ingredient | Aliskiren fumarate | true | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has BoSS | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Aliskiren- and amlodipine- and hydrochlorothiazide-containing product | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Amlodipine | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Aliskiren | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Amlodipine-containing product in oral dose form | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Aliskiren- and hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets